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OBJECTIVE — Thepurposeofthisstudywastoscreenadolescentswithtype1diabetesusing
ambulatorybloodpressuremonitoring(ABPM)to1)testthehypothesisthatusingapresetsleep
time results in an overdiagnosis of abnormal nocturnal dipping in systolic blood pressure and 2)
assess the reproducibility of an abnormal nocturnal systolic blood pressure dip.
RESEARCH DESIGN AND METHODS — For aim 1, ABPM from 53 adolescent pa-
tientswithtype1diabeteswasreviewed.Nocturnaldipsinsystolicbloodpressurecalculatedby
actual sleep time were compared with those from a preset sleep time. For aim 2, blood pressure
monitoring from 98 patients using actual reported sleep time was reviewed. Reproducibility of
the nocturnal dip in systolic blood pressure was assessed in a subset of “nondippers.”
RESULTS — Foraim1,theactualmeanSEdeclineinnocturnalsystolicbloodpressurewas
11.64.7%,whereasthemeandeclineinnocturnalsystolicbloodpressurecalculatedusingthe
preset sleep time was 8.8  4.9% (P  0.0001). For aim 2, 64% of patients had a normal
nocturnal decline in systolic blood pressure (14.9  3.1% mmHg), whereas 36% had an abnor-
mal dip (5.7  2.8% mmHg). Repeat ABPM performed in 22 of the 35 nondippers revealed that
only 36% had abnormal systolic dipping conﬁrmed on the repeat ABPM.
CONCLUSIONS — Theuseofactualreportedsleeptimeisrequiredtoaccuratelydetermine
the nocturnal dip in systolic blood pressure. Repeating ABPM in nondippers is essential to
conﬁrm this abnormality.
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E
levatedbloodpressureisstronglyas-
sociated with diabetic nephropathy
(1–3). However, in the pediatric
population, overt hypertension, as de-
ﬁned by blood pressure 95th percen-
tile, is rarely diagnosed in patients with
type 1 diabetes. Automated blood pres-
sure readings in the ofﬁce are often inac-
curate, and single blood pressure
measurements, whether automated or
manual, are often falsely elevated (4,5).
Mean blood pressure ascertained by 24-h
ambulatory blood pressure monitoring
(ABPM) has also been shown to better
predicttargetorgandamagethanisolated,
intermittent clinic blood pressure mea-
surements in the adult population (6,7).
The American Heart Association has re-
cently presented recommendations for
the use of ABPM in children and adoles-
cents (8).
The use of 24-h ABPM allows obser-
vation of circadian blood pressure pat-
terns by providing a proﬁle of blood
pressure over time (7,9,10). This pattern
includes a normal decrease during sleep
of both systolic and diastolic blood pres-
sure by 10% from daytime levels (7).
In many adolescents and young
adults with type 1 diabetes who are nor-
motensive by standard criteria, there is a
blunted decline in nocturnal systolic
blood pressure compared with that of
age- and sex-matched control subjects
(9). Studies suggest that a loss of the noc-
turnal systolic blood pressure dip may be
a sensitive marker for incipient diabetic
nephropathy (11).
In some studies, preset sleep times of
10:00 P.M.–8:00 A.M. are used for the in-
terpretation of ABPM data (12,13). We
screened a random sample of our adoles-
cents who have type 1 diabetes with
ABPM and noted that although a normal
nocturnal dip was suggested by visual in-
spection of the printed blood pressure
graphswithuseofthepresetsleeptimeof
10:00 P.M.–8:00 A.M., the calculated noc-
turnal dip from the same graphs was fre-
quently abnormal.
The ﬁrst aim of this study was to test
the hypothesis that calculating the noc-
turnal systolic blood pressure dip in ado-
lescentpatientswithtype1diabetesusing
a preset sleep time results in an underes-
timateofthetruenocturnalsystolicblood
pressure dip, thus potentially miscatego-
rizing some individuals as “nondippers”
(see below). The second aim was to assess
thereproducibilityoflossofthenocturnal
dip in systolic blood pressure.
RESEARCH DESIGN AND
METHODS— For aim 1, subjects for
this retrospective analysis were a random
sample of 53 of 400 adolescents with
type1diabetesfollowedinourclinicwho
had agreed to undergo ABPM. Approval
for this analysis was obtained from the
institutional review board.
ABPM
A Spacelabs 90217 portable oscillometric
recorder (Spacelabs, Kaarst, Germany)
was used with four different cuff sizes
(12–20, 17–26, 24–32, and 32–42 cm).
The monitor was worn for 24 h on a non-
school day. The nondominant arm was
measured to ensure correct cuff size, and
thepatientreportedtheanticipatedsleep/
wake times before initializing the moni-
tor. The blood pressure device was set up
to record blood pressure every 20 min
during the day and every 40 min during
the anticipated sleep period. Patients
were instructed to avoid strenuous phys-
ical exertion during the study period.
ABPM was performed in the absence of
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acute infection. Upon returning the mon-
itor, the patient reported actual sleep/
wake times for interpretation of the data.
The nocturnal dip in systolic blood pres-
sure was then calculated based on actual
sleep time and compared with that based
on the preset sleep time of 10:00 P.M.–
8:00 A.M. For the purpose of this study,
nondipping refers to an attenuated fall in
systolic blood pressure during the sleep
period (10%).
For aim 2, ABPM was analyzed from
an additional 45 subjects. For the entire
group, a nocturnal dip in systolic blood
pressure was calculated from the actual
reported sleep time.
After an interval of between 1 and 4
weeks, ABPM was repeated by the same
methodin22ofthe35subjectsidentiﬁed
as nondippers, without major changes in
diet, activity, or insulin regimen. These
subjects were chosen on the basis of their
availability for and cooperation with re-
peatABPMtesting.Noneofthesesubjects
had microalbuminuria, and none had
been treated with any antihypertensive
medication. The nocturnal dip in systolic
blood pressure was again measured using
actual reported sleep time.
Statistical analysis
The statistical software MedCalc (version
9.6.4.0; MedCalc Software, Mariakerke,
Belgium)wasusedforalldataprocessing.
To compare the percent dip in nocturnal
systolic blood pressure using the actual
versus preset sleep time, both a paired t
test and Bland and Altman plot were per-
formed. The 95% CI (P  0.05) was con-
sidered statistically signiﬁcant.
RESULTS— Characteristics of the ini-
tial group of 53 adolescents are shown in
Table 1. On the basis of age, duration of
diabetes, and mean A1C, this group of
adolescents was representative of our en-
tire adolescent population with type 1 di-
abetes. By using the actual reported sleep
time, the mean  SE fall in nocturnal sys-
tolic blood pressure was 11.6  4.7%.
When the mean systolic nocturnal dip
wasmeasuredusingthepresetsleeptime,
the mean fall in nighttime systolic blood
pressure was 8.8  4.9% (P  0.0001)
(Fig. 1). The Brand and Altman plot dem-
onstrates an average discrepancy of 2.8%
with relatively consistent variability
across the graph (Fig. 2). An example of
one adolescent in whom the percent dip
in nocturnal systolic blood pressure cal-
culated from the preset sleep time of
10:00 P.M.–8:00 A.M. was abnormal (4%),
whereas use of the actual reported sleep
time of 2:00–7:00 A.M. identiﬁed a nor-
mal nocturnal dip (13.7%), is shown in
Fig. 3.
Characteristics of the entire group of
98patientsevaluatedisshowninTable2.
Sixty-three(64%)hadanormalnocturnal
declineinsystolicbloodpressure(14.9
3.1%), whereas 35 patients (36%) had an
abnormal dip (5.7  2.8%).
APBM was repeated in 22 of the 35
(63%) patients who had abnormal dip-
ping.Fourteenofthese22(64%)hadnor-
mal nocturnal dipping upon repeat
ABPM, whereas 8 of 22 (36%) had con-
ﬁrmed abnormal dipping.
CONCLUSIONS— Studies have
shown that in patients with type 1 diabe-
tes and incipient nephropathy, loss of the
normal nighttime drop in systolic blood
pressuremayprecedethedevelopmentof
microalbuminuria (9,11,13), which, in
turn, if persistent, strongly predicts the
development of clinical nephropathy
(14,15). This result suggests that noctur-
nal nondipping may be a predictor that
can be used to identify those at risk of
nephropathy. Because the nocturnal dip
is the difference between the mean day-
time (period when ambulatory blood
pressure is higher) and nighttime (period
when the ambulatory blood pressure is
lower) blood pressure, any inclusion of
wakinghoursinthedeﬁnednighttimepe-
riod will result in an increase in the mean
nighttime blood pressure and thereby
cause a reduction in the difference be-
tween the daytime and nighttime blood
pressure.
Some studies have used a preset sleep
time to interpret ABPM data (12,13). We
haveshownthatcalculatingthenocturnal
dip using preset sleep times should be in-
terpreted with caution as this method re-
Figure 1—Comparison of the percent nocturnal dip in systolic blood pressure calculated from
actual sleep time versus that from preset sleep time in 53 subjects with type 1 diabetes.
Table 1—Characteristics of subjects used for comparison of nocturnal dip comparing preset
and actual sleep time
n 53 (27 male, 26 female)
Age (years) 15.1  2.2
Duration of diabetes (years) 6.8  4.2
A1C (%) 8.9  1.8
Bedtime 11:38 P.M.  1.16 h
Wake time 8:31 A.M.  1.46 h
Sleep time 8.8  1.75 h
Data are means  SE.
Nocturnal blood pressure dip in type 1 diabetes
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the prevalence of nondippers. In this co-
hort of adolescents with type 1 diabetes,
when we used a preset sleep time of
10:00 P.M.–8:00 A.M. to interpret the 24-h
ABPM,62%ofthesubjectswereclassiﬁed
asnondippers,whereaswhenweusedthe
actual sleep time, 34% were classiﬁed as
nondippers (data not shown). Although
the mean reported bedtime in our sub-
jects was 11:38 P.M. and mean wake time
was 8:31 A.M., there was a wide range of
bedtime and wake time, probably exacer-
bated by the fact that the study was done
on a Friday (no school the next day).
Some investigators have attempted to
minimize the potential error in calculat-
ing the nocturnal dip by deﬁning the
nighttime period as 12–6 A.M., and the
daytime period as 8 A.M.–10 P.M., i.e.,
eliminating the period of 6–8 A.M. and 10
P.M. to midnight (9,11,16). This practice
minimizes the potential pitfall of using a
presetbedtimebutismorelaborintensive
as the current SpaceLabs software does
not allow times to be eliminated from the
analysis.Whenwemanuallyanalyzedthe
nocturnal dip in our patient using this
method (i.e., deﬁning the nighttime pe-
riod as 12–6 A.M. and the daytime period
as 8 A.M.–10 P.M.), there was concordance
(i.e.,correctcategorizingofthepatientsas
dippers versus nondippers in 85 of 98
[87%] of the subjects. However, in the
remaining 13% of our subjects, there was
discordance, i.e., erroneous categoriza-
tion of their dipping status (data not
shown). This result suggests that when
one is assessing the nocturnal dip in ado-
lescents with type 1 diabetes, elimination
of the “transition hours” is not sufﬁcient,
and actual reported sleep time should be
used.
Admittedly, there is some inaccuracy
in self-reported sleep times, and an even
more precise method would be to deter-
mine sleep time using a device known as
an actigraph to detect motion (17).
Beyond the issue of discerning actual
sleep time to identify blood pressure dip-
ping, there is the question of general
blood pressure reproducibility. One of
the limitations of this study is that we tar-
geted apparent nocturnal nondippers
only. Ideally, a random sample of dippers
should have been undertaken as well.
However,previouslargerstudieshaveex-
amined the general reproducibility of
24-h ABPM. Wang et al. (18) examined
600 healthy adolescents and young
adults and found good overall reproduc-
ibility over many years.
In our study, approximately one-
third of the adolescents with type 1 dia-
betes were found to have an initial
attenuated decline in nighttime systolic
blood pressure on ABPM, despite use of
data from actual sleep times for analysis.
However, of these putative nondippers
who had repeat ABPM performed, almost
two-thirds were found to have normal
nocturnal dipping. Thus, repeat ABPM
reduced the prevalence of nondipping
from 36 to 13%. This result suggests that
ﬁnding a subnormal nocturnal dip in an
adolescent with type 1 diabetes should be
interpreted with caution and that a repeat
Figure 2—Bland and Altman plot. Solid line represents the mean of differences between
percentdeclineinnocturnalsystolicbloodpressure(BP)calculatedusingactualversuspreset
sleep time. The average discrepancy between the different sleep times is 2.8%, with relative
consistent variability.
Figure 3—ABPM from an individual patient. Shaded area indicates sleep time. A: Actual sleep time 2:00–7:00 A.M. Mean daytime systolic blood
pressure (BP) 124 mmHg; mean nighttime systolic blood pressure 107 mmHg; percent dip 13.7%. B: Preset sleep time 10 P.M.–8 A.M. Mean daytime
systolic blood pressure 122 mmHg; mean nighttime systolic blood pressure 117 mmHg; percent dip 4%.
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mality.Itispossiblethatthephenomenon
of “regression to the mean” is partly re-
sponsible for the poor reproducibility of
nondipping. Similar to our ﬁndings, Wang
et al. showed that nocturnal dipping was
somewhat less reproducible than the mea-
sure of either day or night blood pressure,
despite having discarded data from day-
night “transition hours” (18).
Although ABPM has not yet become
routine in monitoring of adolescents with
type 1 diabetes, it offers the ability to
identify subjects with loss of the noctur-
nal dip and, therefore, an apparent in-
creased risk for incipient diabetic
nephropathy. It may be of interest in fu-
ture studies to investigate treating persis-
tent nondippers with renoprotective
drugs before the development of overt
proteinuriaandhypertension.ACEinhib-
itors (19,20) would be a logical choice to
investigate to determine whether 1) they
restore the normal circadian blood pres-
sure pattern in nondippers and 2) this
therapy can prevent the development of
microalbuminuria.
On the basis of our ﬁndings, caution
should be exercised when one is interpret-
ing the nocturnal blood pressure proﬁle
with ABPM. When the nocturnal dip is cal-
culated with software that uses the entire
24-hperiod,itisimportanttousetheactual
reported sleep time rather than a preset
sleep time for the analysis. In addition, it is
essential to conﬁrm abnormal nocturnal
dipping by repeating the ABPM.
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